Drug Absorption Studies.
SCHAFER-KORTING, M., BOCK, U., DIEMBECK, W., DUSING, H. J., GAMER,
A., et al. 2008. The use of reconstructed human epidermis for
skin absorption testing: Results of the validation study. Altern
Lab Anim, 36, 161-87.
SCHMOOK, F. P., MEINGASSNER, J. G. & BILLICH, A. 2001. Comparison of
human skin or epidermis models with human and animal skin in in-vitro
percutaneous absorption. Int J Pharm, 215, 51-6.
SCHREIBER, S., MAHMOUD, A., VUIA, A., RUBBELKE, M. K., SCHMIDT,
E., et al. 2005. Reconstructed epidermis versus human and animal
skin in skin absorption studies. Toxicol In Vitro, 19,813-22.
SCHRODER, H., KOMLJENOVIC, D., HECKER, M. & KORFF, T. 2016. Transdermal
drug targeting and functional imaging of tumor blood vessels in the
mouse auricle. Faseb j, 30, 923-32.
SCOGNAMIGLIO, I., DE STEFANO, D., CAMPANI, V., MAYOL, L., CARNUCCIO,
R., et al. 2013. Nanocarriers for topical administration of
resveratrol: A comparative study. International Journal of
Pharmaceutics, 440, 179-187.
ŞENYIĞIT, T., SONVICO, F., BARBIERI, S., ÖZER, Ö., SANTI, P., et
al. 2010. Lecithin/chitosan nanoparticles of clobetasol-17-propionate
capable of accumulation in pig skin. Journal of Controlled
Release, 142, 368-373.
SHAH, V. P., ELKINS, J., LAM, S.-Y. & SKELLY, J. P. 1989. Determination
of in vitro drug release from hydrocortisone creams. International
Journal of Pharmaceutics, 53, 53-59.
SHAKEL, Z., NUNES, C., COSTA LIMA, S. A. & REIS, S. 2019. Development
of a novel human stratum corneum model, as a tool in the optimization of
drug formulations. International Journal of Pharmaceutics,569, 118571.
SHEPHERD, J., LITTLE, M. C. & NICKLIN, M. J. H. 2004. Psoriasis-Like
Cutaneous Inflammation in Mice Lacking Interleukin-1 Receptor
Antagonist. Journal of Investigative Dermatology, 122,665-669.
SILVA, E., BARREIROS, L., SEGUNDO, M. A., COSTA LIMA, S. A. & REIS, S.
2017. Cellular interactions of a lipid-based nanocarrier model with
human keratinocytes: Unravelling transport mechanisms. Acta
Biomaterialia, 53, 439-449.
SINGH, A., SINGH, A., SAND, J. M., BAUER, S. J., HAFEEZ, B. B., et
al. 2015. Topically applied Hsp90 inhibitor 17AAG inhibits UVR-induced
cutaneous squamous cell carcinomas. The Journal of investigative
dermatology, 135, 1098-1107.
SINKO, B., GARRIGUES, T. M., BALOGH, G. T., NAGY, Z. K., TSINMAN,
O., et al. 2012. Skin-PAMPA: a new method for fast prediction of
skin penetration. Eur J Pharm Sci, 45, 698-707.
SINKÓ, B., VIZSERÁLEK, G. & TAKÁCS-NOVÁK, K. 2014. Skin PAMPA:
Application in practice. ADMET & DMPK, 2, 191-198.
SOFIA A. COSTA LIMA., R., S. 2018. Nanotechnological approaches in drug
absorption through skin topical delivery. In: PUBLISHING, J. S.
(ed.) Nanoparticles in Life Sciences and Biomedicine. New York.
SRIRAM, G., ALBERTI, M., DANCIK, Y., WU, B., WU, R., et al. 2018.
Full-thickness human skin-on-chip with enhanced epidermal morphogenesis
and barrier function. Materials Today, 21, 326-340.
SZABOWSKI, A., MAAS-SZABOWSKI, N., ANDRECHT, S., KOLBUS, A.,
SCHORPP-KISTNER, M., et al. 2000. c-Jun and JunB Antagonistically
Control Cytokine-Regulated Mesenchymal–Epidermal Interaction in Skin.Cell, 103, 745-755.
TABART, J., BALDO, A., VERMOUT, S., LOSSON, B. & MIGNON, B. 2008.
Reconstructed interfollicular feline epidermis as a model for the
screening of antifungal drugs against Microsporum canis.Veterinary Dermatology, 19, 130-133.
TANAKA, A., AMAGAI, Y., OIDA, K. & MATSUDA, H. 2012. Recent Findings in
Mouse Models for Human Atopic Dermatitis. Experimental Animals,61, 77-84.
TANG, T., TANG, J. Y., LI, D., REICH, M., CALLAHAN, C. A., et al.2011. Targeting superficial or nodular Basal cell carcinoma with
topically formulated small molecule inhibitor of smoothened. Clin
Cancer Res, 17, 3378-87.
TARASSOLI, S. P., JESSOP, Z. M., AL-SABAH, A., GAO, N., WHITAKER,
S., et al. 2018. Skin tissue engineering using 3D bioprinting: An
evolving research field. Journal of Plastic, Reconstructive &
Aesthetic Surgery, 71, 615-623.
TERNULLO, S., BASNET, P., HOLSÆTER, A. M., FLATEN, G. E., DE WEERD,
L., et al. 2018. Deformable liposomes for skin therapy with human
epidermal growth factor: The effect of liposomal surface charge.European Journal of Pharmaceutical Sciences, 125,163-171.
TERNULLO, S., DE WEERD, L., FLATEN, G. E., HOLSÆTER, A. M. &
ŠKALKO-BASNET, N. 2017a. The isolated perfused human skin flap model: A
missing link in skin penetration studies? European Journal of
Pharmaceutical Sciences, 96, 334-341.
TERNULLO, S., DE WEERD, L., HOLSÆTER, A. M., FLATEN, G. E. &
ŠKALKO-BASNET, N. 2017b. Going skin deep: A direct comparison of
penetration potential of lipid-based nanovesicles on the isolated
perfused human skin flap model. European Journal of Pharmaceutics
and Biopharmaceutics, 121, 14-23.
THANG, N. D., YAJIMA, I., NAKAGAWA, K., TSUZUKI, T., KUMASAKA, M.
Y., et al. 2012. A novel hairless mouse model for malignant
melanoma. J Dermatol Sci, 65, 207-12.
TJABRINGA, G., BERGERS, M., VAN RENS, D., DE BOER, R., LAMME, E.,
et al. 2008. Development and validation of human psoriatic skin
equivalents. The American journal of pathology, 173,815-823.
TROTTIER, V., MARCEAU-FORTIER, G., GERMAIN, L., VINCENT, C. & FRADETTE,
J. 2008. IFATS Collection: Using Human Adipose-Derived Stem/Stromal
Cells for the Production of New Skin Substitutes. STEM CELLS,26, 2713-2723.
TSINMAN, K. & SINKÓ, B. 2013. A high throughput method to predict skin
penetration and screen topical formulations. Cosmet Toiletries,128, 192-199.
UCHECHI, O., OGBONNA, J. D. N. & ATTAMA, A. A. 2014. Nanoparticles for
Dermal and Transdermal Drug Delivery. Application of
Nanotechnology in Drug Delivery.
UCHIDA, T., KADHUM, W. R., KANAI, S., TODO, H., OSHIZAKA, T., et
al. 2015. Prediction of skin permeation by chemical compounds using the
artificial membrane, Strat-M. Eur J Pharm Sci, 67,113-118.
UCHIDA, Y. & PARK, K. 2016. Stratum Corneum. In: KABASHIMA, K.
(ed.) Immunology of the Skin: Basic and Clinical Sciences in Skin
Immune Responses. Tokyo: Springer Japan.
UCHINO, T., TAKEZAWA, T. & IKARASHI, Y. 2009. Reconstruction of
three-dimensional human skin model composed of dendritic cells,
keratinocytes and fibroblasts utilizing a handy scaffold of collagen
vitrigel membrane. Toxicology in Vitro, 23, 333-337.
VAN DEN BROEK, L. J., BERGERS, L., REIJNDERS, C. M. A. & GIBBS, S.
2017. Progress and Future Prospectives in Skin-on-Chip Development with
Emphasis on the use of Different Cell Types and Technical Challenges.Stem Cell Rev, 13, 418-429.
VAN GELE, M., GEUSENS, B., BROCHEZ, L., SPEECKAERT, R. & LAMBERT, J.
2011. Three-dimensional skin models as tools for transdermal drug
delivery: challenges and limitations. Expert Opin Drug Deliv,8, 705-20.
VAN RAVENZWAAY, B. & LEIBOLD, E. 2004. A comparison between in vitro
rat and human and in vivo rat skin absorption studies. Hum Exp
Toxicol, 23, 421-30.
VESTERGAARD, C., YONEYAMA, H., MURAI, M., NAKAMURA, K., TAMAKI,
K., et al. 1999. Overproduction of Th2-specific chemokines in
NC/Nga mice exhibiting atopic dermatitis–like lesions. The
Journal of Clinical Investigation, 104, 1097-1105.
VIZSERÁLEK, G., BERKÓ, S., TÓTH, G., BALOGH, R., BUDAI-SZŰCS, M.,
et al. 2015. Permeability test for transdermal and local therapeutic
patches using Skin PAMPA method. European Journal of
Pharmaceutical Sciences, 76, 165-172.
VORSMANN, H., GROEBER, F., WALLES, H., BUSCH, S., BEISSERT, S., et
al. 2013. Development of a human three-dimensional organotypic
skin-melanoma spheroid model for in vitro drug testing. Cell Death
Dis, 4, e719.
WALTERS, K. A. & ROBERTS, M. S. 2002. The Structure and Function of
Skin. Dermatological and Transdermal Formulations. CRC Press.
WANG, H., LI, J., LV, T., TU, Q., HUANG, Z., et al. 2013.
Therapeutic and immune effects of 5-aminolevulinic acid photodynamic
therapy on UVB-induced squamous cell carcinomas in hairless mice.Exp Dermatol, 22, 362-3.
WATKINSON, R. M., GUY, R. H., HADGRAFT, J. & LANE, M. E. 2009a.
Optimisation of Cosolvent Concentration for Topical Drug Delivery – II:
Influence of Propylene Glycol on Ibuprofen Permeation. Skin
Pharmacology and Physiology, 22, 225-230.
WATKINSON, R. M., GUY, R. H., OLIVEIRA, G., HADGRAFT, J. & LANE, M. E.
2011. Optimisation of Cosolvent Concentration for Topical Drug Delivery
III – Influence of Lipophilic Vehicles on Ibuprofen Permeation.Skin Pharmacology and Physiology, 24, 22-26.
WATKINSON, R. M., HERKENNE, C., GUY, R. H., HADGRAFT, J., OLIVEIRA,
G., et al. 2009b. Influence of Ethanol on the Solubility,
Ionization and Permeation Characteristics of Ibuprofen in Silicone and
Human Skin. Skin Pharmacology and Physiology, 22, 15-21.
WEINHART, M., HOCKE, A., HIPPENSTIEL, S., KURRECK, J. & HEDTRICH, S.
2019. 3D organ models—Revolution in pharmacological research?Pharmacological Research, 139, 446-451.
WONGLERTNIRANT, N., NGAWHIRUNPAT, T. & KUMPUGDEE-VOLLRATH, M. 2012.
Evaluation of the mechanism of skin enhancing surfactants on the
biomembrane of shed snake skin. Biol Pharm Bull, 35,523-31.
WORTH, A. P., FENTEM, J. H., BALLS, M., BOTHAM, P. A., CURREN, R.
D., et al. 1998. An evaluation of the proposed OECD testing
strategy for skin corrosion. Atla-Alternatives to Laboratory
Animals, 26, 709-720.
WU, H., DENG, Z., ZHOU, B., QI, M., HONG, M., et al. 2019.
Improved transdermal permeability of ibuprofen by ionic liquid
technology: Correlation between counterion structure and the
physicochemical and biological properties. Journal of Molecular
Liquids, 283, 399-409.
WU, S. T., SHIU, G. K., SIMMONS, J. E., BRONAUGH, R. L. & SKELLY, J. P.
1992. In vitro release of nitroglycerin from topical products by use of
artificial membranes. J Pharm Sci, 81, 1153-6.
YU, J. R., NAVARRO, J., COBURN, J. C., MAHADIK, B., MOLNAR, J., et
al. 2019. Current and Future Perspectives on Skin Tissue Engineering:
Key Features of Biomedical Research, Translational Assessment, and
Clinical Application. Advanced Healthcare Materials, 8,1801471.
YU, X., DU, L., ZHU, L., LIU, X., ZHANG, B., et al. 2016.
Melanoma therapy with transdermal mitoxantrone cubic phases. Drug
Deliv, 23, 1565-70.
YUE, L., HUANG, Z. M., FONG, S., LEONG, S., JAKOWATZ, J. G., et
al. 2015. Targeting ALDH1 to decrease tumorigenicity, growth and
metastasis of human melanoma. Melanoma Res, 25, 138-48.
YUN, Y. E., JUNG, Y. J., CHOI, Y. J., CHOI, J. S. & CHO, Y. W. 2018.
Artificial skin models for animal-free testing. Journal of
Pharmaceutical Investigation, 48, 215-223.
ZBYTOVSKÁ, J., KISELEV, M. A., FUNARI, S. S., GARAMUS, V. M., WARTEWIG,
S., et al. 2008. Influence of cholesterol on the structure of
stratum corneum lipid model membrane. Colloids and Surfaces A:
Physicochemical and Engineering Aspects, 328, 90-99.
ZHANG, H., ZHU, X., SHEN, J., XU, H., MA, M., et al. 2016.
Characterization of a liposome-based artificial skin membrane for in
vitro permeation studies using Franz diffusion cell device.Journal of Liposome Research, 27, 302-311.
ZHANG, Q., SITO, L., MAO, M., HE, J., ZHANG, Y. S., et al. 2018.
Current advances in skin-on-a-chip models for drug testing.Microphysiological Systems, 2.
ZHANG, Y., LANE, M. E., HADGRAFT, J., HEINRICH, M., CHEN, T., et
al. 2019. A comparison of the in vitro permeation of niacinamide in
mammalian skin and in the Parallel Artificial Membrane Permeation Assay
(PAMPA) model. International Journal of Pharmaceutics,556, 142-149.